|
||||||||||||||||||||||
|
|
Alternate Title Randomized Study of Health Education Counseling With Versus Without Bupropion Hydrochloride in African-Americans Who Are Light Smokers
Trial Description A stop-smoking plan that includes health education counseling and bupropion may help African-American smokers stop smoking. It is not yet known whether health education counseling is more effective with or without bupropion in helping African Americans stop smoking. This clinical trial is studying health education counseling and bupropion to see how well they work compared with a placebo and health education counseling in helping African Americans smokers stop smoking. Eligibility criteria include the following:
Final eligibility for a clinical trial is determined by the health professionals conducting the trial. Participants will be randomly assigned (have an equal chance of being placed) to one of two groups. Participants in group one will receive bupropion by mouth once or twice a day for 7 weeks. They will also receive health education counseling sessions during clinic visits in weeks 1, 4, and 8 and over the telephone in weeks 2, 6, and 17. During the health education counseling sessions, participants will receive a culturally-sensitive stop-smoking guide to discuss with their counselor and information about the risks of continued smoking and the benefits of stopping smoking. They will also develop a plan to stop smoking and learn about building social support, reducing stress, recognizing and managing withdrawal and craving, overcoming barriers, and use of medication to stop smoking. Participants in group two will receive a placebo by mouth once or twice a day for 7 weeks. They will also receive health education counseling sessions during clinic visits in weeks 1, 4, and 8 and over the telephone in weeks 2, 6, and 17. During the health education counseling sessions, participants will receive a culturally-sensitive stop-smoking guide to discuss with their counselor and information about the risks of continued smoking and the benefits of stopping smoking. They will also develop a plan to stop smoking and learn about building social support, reducing stress, recognizing and managing withdrawal and craving, overcoming barriers, and use of medication to stop smoking. Participants will fill out questionnaires in week 1. Participants will undergo blood sample collection in weeks 1 and 4 for laboratory studies. Before blood sample collection in week 1, participants will smoke one cigarette. Some participants will also undergo saliva sample collection in weeks 8 and 27 for laboratory studies. After finishing the study, patients will be evaluated at 6 months. Important: For more details about this trial, refer to the Health Professional version of the trial summary. If you are interested in participating in a clinical trial, contact your doctor for a referral or call a trial contact person listed below. You may see the same contact person listed at more than one site, however, if you call the number listed you can ask to speak to the study coordinator or person involved with the specific trial you are interested in. If you have questions about cancer or clinical trials, call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237). General information about clinical trials, including risks, benefits, and costs, can be found on NCI's Web site. Trial Lead Organizations Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
|
NCI Home |
Images Version |
Contact Us |
Policies |
Accessibility |
Viewing Files |
FOIA |
Site Help |
Site Map
|
A Service of the National Cancer Institute |